Medical Robotic Systems Market Size to Reach USD 102.96 Billion in 2032
The Medical Robotic Systems Market size was USD 29.59 billion in 2024 and is expected to register a revenue CAGR of 16.8% during the forecast period
22 February, 2024 – Growing adoption of minimally invasive surgeries is a key driver driving the medical robotic systems market. Minimally invasive robotic surgery is an alternative to traditional approaches that allows surgeons to conduct a wide range of complex procedures with more precision, flexibility, and control. The most extensively used minimally invasive surgical robotic systems consist of a robotic arm with a camera and additional robotic arms with surgical instruments attached.
The advancement of robotic-assisted surgery has reduced patients’ postoperative discomfort and recovery periods while also broadening the spectrum of what is surgically possible. Despite hurdles, the robotic revolution is a monument to the unwavering quest of excellence in medicine, with the potential to reshape the landscape of surgical practice in the years ahead. The implementation of robotic-assisted surgery has highlighted the necessity for specific training programs.
On May 2024, Richtech Robotics Inc., a Nevada-based manufacturer of AI-powered service robots, announced the release of its latest robot, Medbot, an elevator delivery robot meant to streamline pharmacy operations by delivering medications continuously, around the clock. Medbot’s high operational accuracy enhances healthcare facility efficiency through secure delivery, lowering operating costs and increasing the overall patient experience. Medbot advances Richtech Robotics’ aim of creating high-quality, stable robots that raise employee happiness and improve customer profitability.
However, concerns about system reliability and malfunctions, stringent regulatory reforms for patient safety acts as challenges for growth of medical robotic systems market. The most common types of robotic malfunctions (RMs) are instrument changes, mechanical arm changes, console faults, optical system problems, and software concerns. The frequency of flaws is mostly determined by the type of robotic device, the manufacturer, and the extent to which various robot versions are updated. One of the main causes of instrument malfunction is the wear of the insulating membrane caused by friction and collision among devices inside the abdomen, or during their insertion through trocars.
Key Highlights:
- Surgical robots segment is expected to register the largest market revenue share over the forecast period. Robotic surgical technologies provide surgeons with precise, accurate, and easily replicable results, which can significantly enhance patient outcomes. Because of their effectiveness, over 1,700 da Vinci Systems are currently installed in hospitals throughout the world, and more than 775,000 patients have undergone treatments using this robotic surgical system. With over 75% of all prostate cancer procedures in the United States performed with da Vinci devices, this robotic platform has proven itself as a successful and dependable instrument.
- Software segment is expected to account for the fastest growth rate over the forecast period. AI in medical robotics represents a ground-breaking collaboration between computational intelligence and mechanical processes. AI-powered robots can evaluate large amounts of data in real time and aid surgeons during procedures. As AI algorithms advance and technology becomes more available, the role of robots in healthcare is set to expand, ushering in a new era of medical treatment that values precision, efficiency, and, most importantly, patient care.
- North America accounted for largest market revenue share in the medical robotic systems market in 2024 due to the adoption of minimally invasive surgeries and technological advancements such as incorporating AI in robots. On September 2023, US Medical Innovations (USMI) and the Jerome Canady Research Institute for Advanced and Biological Technological Sciences (JCRI-ABTS) have unveiled the revolutionary Canady Robotic AI Surgical System. The Canady Robotic AI Surgical System is the world’s first AI robotic system to use cold atmospheric plasma (CAP), a three-dimensional non-contact bioelectric pulse electromagnetic field. CAP selectively targets and destroys tiny tumor cells during surgery while sparing non-cancerous surrounding tissue.
- Some major companies in the market report include Intuitive Surgical, Inc., Medtronic plc, Olympus Corporation, Stryker Corporation, Boston Scientific Corporation, Asensus Surgical, Inc, Smith & Nephew, Titan Medical Inc., Avatera Medical GmbH, Renishaw plc, EndoMaster Pte Ltd, Johnson & Johnson, Brainlab AG, CMR Surgical Ltd., and Siemens Healthineers GmbH.
- On August 2024, Vicarious Surgical Inc., a next-generation robotics technology firm that aims to enhance lives by changing robotic surgery, has struck a strategic development partnership with LSU Health New Orleans. Vicarious Surgical will get access to the LSU Health New Orleans network and will be able to work directly with the team’s experienced robotic surgeons and support staff. The cooperation will use LSU Health New Orleans’ considerable surgeon training expertise to assess training processes and uncover potential drivers of surgeon adoption.
- On October 2022, THINK Surgical, a technological developer producing orthopaedic surgical robots, revealed that a new investor, KDB Investment Global Healthcare of Korea, has invested USD 100 million in the firm to accelerate the commercial launch of numerous innovative technologies. This investment will enable THINK Surgical to deliver new technologies to market that will provide a single planning solution across several robotic systems, as well as a selection of implants from other manufacturers. This investment will allow THINK Surgical to realize its full potential as a leader in the orthopaedic surgical robot market, with a unique business strategy.
Unlock the key to transforming your business strategy with our medical robotic systems market insights –
Get a preview of the complete research study
Navistrat Analytics has segmented medical robotic systems market based on product type, component, automation level, and end-use:
- Product Type Outlook (Revenue, USD Billion; 2022-2032)
- Surgical Robots
- Laparoscopy Robots
- Orthopedic Robots
- Neurosurgical Robots
- Cardiovascular Surgery Robots
- Gynecological Surgery Robots
- Urology Surgery Robots
- Others
- Rehabilitation Robots
- Therapeutic Robots
- Exoskeleton Robots
- Prosthetic Robotics
- Others
- Non-invasive Radiosurgery Robots
- CyberKnife
- GammaKnife
- Linear Accelerator Systems (LINAC)
- Others
- Hospital & Pharmacy Automation Robots
- IV Robots
- Pharmacy Dispensing Robots
- Cart Transportation Robots
- Automated Guided Vehicles (AGVs)
- Others
- Diagnostic Robots
- Telemedicine Robots
- Others
- Surgical Robots
- Component Outlook (Revenue, USD Billion; 2022-2032)
- Hardware
- Sensors
- Robotic Arms
- Control Systems
- Actuators
- Others
- Software
- Operating Systems
- Simulation Software
- Data Analysis Platforms
- Others
- Services
- Maintenance Services
- Integration Services
- Training Services
- Consultancy Services
- Hardware
- Automation Level Outlook (Revenue, USD Billion; 2022-2032)
-
- Autonomous
- Semi-Autonomous
- Manual-Assisted
-
- End-Use Outlook (Revenue, USD Billion; 2022-2032)
-
- Hospitals
- Ambulatory Surgical Centers (ASCs)
- Diagnostic Centers
- Rehabilitation Centers
- Pharmacy and Compounding Centers
- Research and Academic Institutions
- Others
-
- Regional Outlook (Revenue, USD Billion; 2022-2032)
-
-
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Spain
- Benelux
- Nordic Countries
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- South Korea
- Oceania
- ASEAN Countries
- Rest of APAC
- Latin America
- Brazil
- Rest of LATAM
- Middle East & Africa
- GCC Countries
- South Africa
- Israel
- Turkey
- Rest of MEA
- North America
-